Jeremiah A Alt1, Andrew J Thomas1, Karen Curtin2,3, Jathine Wong3, Luke Rudmik4, Richard R Orlandi1. 1. Division of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, UT. 2. Department of Medicine, University of Utah, Salt Lake City, UT. 3. Pedigree and Population Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. 4. Division of Otolaryngology-Head and Neck Surgery, University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND: Chronic rhinosinusitis (CRS) is a highly prevalent inflammatory condition, with significant effects on morbidity and quality of life. Given that other chronic inflammatory conditions have been associated with increased mortality risk, we sought to evaluate the relationship between mortality and CRS including the influence of asthma. Our objective was to determine if CRS, with or without asthma, is associated with altered risk of mortality. METHODS: Using a statewide population database, we retrospectively identified 27,005 patients diagnosed with CRS between 1996 and 2012, and 134,440 unaffected controls matched 5:1 on birth year and sex. Risk of mortality was determined from Cox models and Kaplan-Meier curves were used to compare survival. RESULTS: A significant interaction between CRS and asthma status was observed in which CRS appeared to confer a protective effect in asthma patients. Asthma, when present, increased mortality in CRS-negative controls (p-interaction < 0.0001). Independent of asthma status, CRS patients exhibited a decreased mortality risk (hazard ratio [HR] = 0.80; 95% confidence interval [CI], 0.74 to 0.85) compared to controls. However, in patients diagnosed at or before the median age of CRS onset (42 years) independent of asthma status, survival was not improved (HR = 0.98; 95% CI, 0.81 to 1.18). Risk of mortality was greater in CRS with nasal polyps (n = 1643) compared to 25,362 polyp-negative CRS patients (HR = 1.38; 95% CI, 1.09 to 1.77). CONCLUSION: CRS was associated with lower risk of mortality compared to controls, and appeared to mitigate increased mortality from asthma. We posit that better survival conferred by CRS may be secondary to treatment. However, the etiology of this relationship and the effect of CRS treatment on mortality are unknown.
BACKGROUND:Chronic rhinosinusitis (CRS) is a highly prevalent inflammatory condition, with significant effects on morbidity and quality of life. Given that other chronic inflammatory conditions have been associated with increased mortality risk, we sought to evaluate the relationship between mortality and CRS including the influence of asthma. Our objective was to determine if CRS, with or without asthma, is associated with altered risk of mortality. METHODS: Using a statewide population database, we retrospectively identified 27,005 patients diagnosed with CRS between 1996 and 2012, and 134,440 unaffected controls matched 5:1 on birth year and sex. Risk of mortality was determined from Cox models and Kaplan-Meier curves were used to compare survival. RESULTS: A significant interaction between CRS and asthma status was observed in which CRS appeared to confer a protective effect in asthmapatients. Asthma, when present, increased mortality in CRS-negative controls (p-interaction < 0.0001). Independent of asthma status, CRSpatients exhibited a decreased mortality risk (hazard ratio [HR] = 0.80; 95% confidence interval [CI], 0.74 to 0.85) compared to controls. However, in patients diagnosed at or before the median age of CRS onset (42 years) independent of asthma status, survival was not improved (HR = 0.98; 95% CI, 0.81 to 1.18). Risk of mortality was greater in CRS with nasal polyps (n = 1643) compared to 25,362 polyp-negative CRSpatients (HR = 1.38; 95% CI, 1.09 to 1.77). CONCLUSION:CRS was associated with lower risk of mortality compared to controls, and appeared to mitigate increased mortality from asthma. We posit that better survival conferred by CRS may be secondary to treatment. However, the etiology of this relationship and the effect of CRS treatment on mortality are unknown.
Authors: Gretchen M Oakley; Karen Curtin; Quinn Orb; Carole Schaefer; Richard R Orlandi; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2015-02-12 Impact factor: 3.858
Authors: Sarah L Appleton; Richard E Ruffin; David H Wilson; Anne W Taylor; Robert J Adams Journal: J Allergy Clin Immunol Date: 2009-01 Impact factor: 10.793
Authors: Alexis Ogdie; Kevin Haynes; Andrea B Troxel; Thorvardur Jon Love; Sean Hennessy; Hyon Choi; Joel M Gelfand Journal: Ann Rheum Dis Date: 2012-12-21 Impact factor: 19.103